Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19
젤라틴은 COVID-19에 대한 폐 약물 전달에서 분무된 단백질을 안정화합니다
Article
Published on
Journal: ACS Biomaterials Science & Engineering
[Category] Coronavirus, COVID19(2023년), SARS, 변종,
Journal: ACS Biomaterials Science & Engineering
[Category] Coronavirus, COVID19(2023년), SARS, 변종,
[키워드] ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
addition
Aerogen
airway
angiotensin
angiotensin-converting enzyme 2
biological molecule
biological molecules
can be used
coordination
coronavirus
CoV-19
COVID-19
delivery
distribution
domain
dosage
drug
effective
ENhance
enzyme
experiment
experiments
feasibility
fraction
Fractions
gelatin
gelatin stabilization
generate
IFN-α2
infection with SARS-CoV-2
inhalation
inhalation therapy
inhibit
interferon
lung
Lungs
medication
nebulization
noninvasive
pandemic
Protein
protocol
pulmonary
pulmonary delivery.
RBD-62
respiratory diseases
SARS-CoV-2
significantly
therapy
transfer
Vaccines
variants
[DOI] 10.1021/acsbiomaterials.2c00419 PMC 바로가기 [Article Type] Article
[DOI] 10.1021/acsbiomaterials.2c00419 PMC 바로가기 [Article Type] Article